Table 1. Cell Viability Data for Compound 8·2Cl and Doxorubicin for the 10 Cell Lines Tested.
cell viability (%) |
||
---|---|---|
cell line | 8·2Cl | doxorubicin |
FaDu | 20.6 ± 1.1 | 72.2 ± 0.9 |
SKMEL-2 | 7.2 ± 2.5 | 6.9 ± 7.3 |
HT-29 | 14.9 ± 1.7 | 54.3 ± 0.9 |
HT-1080 | 35.6 ± 1.8 | 56.3 ± 5.5 |
HepG2 | 66.8 ± 5.2 | 74.9 ± 1.0 |
HL-60 | 51.1 ± 3.4 | 4.0 ± 2.5 |
Jurkat | 28.9 ± 1.9 | 6.7 ± 0.9 |
PC-3 | 45.6 ± 1.2 | 59.7 ± 1.1 |
HeLa | 32.3 ± 1.8 | 3.9 ± 4.0 |
MDA-MB-231 | 66.1 ± 3.5 | 61.1 ± 1.3 |